Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?

• প্রধান লেখক: Özge Kaya (লেখক), Zeynep Keskinkaya (লেখক), Selda Işık Mermutlu (লেখক), Sevilay Oğuz Kılıç (লেখক), Sevgi Öztürk (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Mattioli1885, 2023-07-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Introduction: Based on the existing literature, omalizumab (OMZ) is considered a safe treatment modality in chronic spontaneous urticaria (CSU) during the coronavirus disease 19 (COVID-19) era.  Objectives: The aim of this study is to evaluate the effects of OMZ on CSU patients regarding COVID-19 in...